We help clients assess chemical compound safety to develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals, and consumer products. At the frontline of next generation risk assessment (NGRA), we develop customized cell-based assays to determine safety, model chemical disposition in the body, and analyze and interpret genetic data. Our solutions save our clients time and money by bringing their products to market faster.
Latest News (See all)
ScitoVation launched its new Collaborative Partnering Program (CPP) designed to engage industry consultants to promote the use of 21st-century safety assessment methods and new alternative methods (NAMS) with their clients.… Read more »
Dr. Moreau – Manager of the company’s PBPK (Physiologically based pharmacokinetic modeling) division has been selected to receive the 2019 Health Products, and Food Branch Assistant Deputy Minister’s Award for… Read more »
ScitoVation and BioSpyder are excited to introduce our new transcriptomics analysis package, ScitoXpress™. ScitoXpress™ provides important information about points of departure (POD) and potential modes of action (MoA) for our clients’ compounds. ScitoXpress™ characterizes chemical risk cost-efficiently and rapidly.
Because changes in gene expression precede changes in phenotype, a robust transcriptomics package like ScitoXpress™ can provide answers at lower doses compared to disease or tumor endpoints are typical used in in vivo studies. ScitoXpress™ offers the additional advantages of:
- Providing utility in guiding additional studies, resulting in cost- and time-savings
- Being based on a rigorous scientific approach, applied by experts
- Having the support of U.S. EPA
Learn more about ScitoXpress™ during our webinar on Thursday, April 4th. We look forward to sharing more with you!
Who We Serve
By combining modern biological and computational methods, we help our clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products.
Whether you are a client, prospective client, prospective employee, a partner or general member of the public, thank you for your interest in ScitoVation and for visiting our Internet site.… Read more »
ScitoVation will be attending the 2019 Society of Toxicology (SoT) conference in Baltimore on March 10-14. Visit us at booth 3218 in the exhibit hall, or see one of our… Read more »
Identifying Lowest Dosage where Bioactivity Occurs and Mode of Action ScitoVation is pleased to introduce the ScitoXpress™ package, enabling us to conduct in vitro transcriptomics studies on client compounds to… Read more »